|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Acquired in-process research and development | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net: | |||||
| Interest expense | |||||
| Interest income | |||||
| Other (expense) income, net | |||||
| Total other income (expense), net | |||||
| Other income (expense), net | |||||
| Total other income, net | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive (loss) income, net: | |||||
| Unrealized loss on available-for-sale securities, net | |||||
| Foreign currency translation (loss) gain | |||||
| Total other comprehensive (loss) income, net | |||||
| Comprehensive loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average number of common shares outstanding, basic | |||||
| Weighted-average number of common shares outstanding, diluted | |||||
Loading...